Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 293
Selected: 0
NCT IDTitle
NCT00630253Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
NCT00176839Stem Cell Transplantation for Hematological Malignancies
NCT03365661QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
NCT05363267NF-1, Nutraceutical Intervention
NCT03054909IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer
NCT05708703Assessing the Time Demands of Cancer
NCT01505569Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
NCT01639456CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
NCT02999399Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism
NCT02156674Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
NCT01012362Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
NCT05308316Sugars in Cigarettes
NCT03946423BAriaTric Surgery After Breast Cancer Treatment (BATS)
NCT00258362Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
NCT05805605Allo HSCT Using RIC and PTCy for Hematological Diseases
NCT04426669A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
NCT03081780Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML
NCT03579875Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
NCT00167219Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
NCT00376519Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
NCT07560865First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma
NCT02227797MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT03934840CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
NCT00176826T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
NCT06772090Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies
NCT00889408DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma
NCT04928950Charcoal in Lung Cancer Patients Undergoing TEMLA
NCT00287859Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT03314974Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT00668564Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
NCT00176904Stem Cell Transplant for Inborn Errors of Metabolism
NCT06411795Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy
NCT00354172Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
NCT00352118Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
NCT05322408HCW9218 in Select Advanced Solid Tumors
NCT00005984Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia
NCT04530695Diagnosis and Treatment of Periodontal Disease in Patients With AML
NCT03674411Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
NCT01677949Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
NCT00652899Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
NCT00005993Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer
NCT00680667Clinical Trial of Trametes Versicolor in Women With Breast Cancer
NCT01144442WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
NCT00602446Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
NCT00276159Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
NCT02605421Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
NCT00295880Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
NCT02661035Allo HSCT Using RIC for Hematological Diseases
NCT01560923Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS